Interchemie Werken De Adelaar Eesti aktsiaselts
Active Registry code 10009120
AS Püünsi küla Registered 31 Jan 1996
Interchemie Werken De Adelaar Eesti aktsiaselts is a AS based in Püünsi küla, registry code 10009120, status: active. Main activity: Manufacture of pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €10 298 033 with 142 employees.
Turnover
10 298 033 €
↓ 2.6% vs Q2 2026
State taxes
0 €
↓ 100.0% vs Q2 2026
Labour taxes
435 399 €
↑ 0.3% vs Q2 2026
Employees
142
+1 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 10.3 mn €above 98% of companiesindustry median 234 187 € · companies in the industry: 12
- Labour taxes per employee 3 066 €above 26% of companiesindustry median 4 573 € · companies in the industry: 12
- Revenue · 2024 25.5 mn €above 98% of companiesindustry median 25 284 € · companies in the industry: 24
- Net profit margin · 2024 -22.0 %above 30% of companiesindustry median 1.2 % · companies in the industry: 17
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 10 298 033 | — | 435 399 | 142 |
| Q2 2026 | 10 575 212 | 233 359 | 434 147 | 141 |
| Q1 2026 | 23 305 674 | 779 817 | 590 023 | 137 |
| Q4 2025 | 11 919 114 | 813 436 | 743 686 | 162 |
| Q3 2025 | 7 505 119 | 266 906 | 805 163 | 193 |
| Q2 2025 | 11 346 544 | 112 928 | 749 471 | 194 |
| Q1 2025 | 6 545 978 | 231 422 | 632 125 | 183 |
| Q4 2024 | 6 099 839 | 155 946 | 567 685 | 167 |
| Q3 2024 | 8 431 711 | 133 776 | 646 149 | 174 |
| Q2 2024 | 9 992 635 | 11 053 | 566 640 | 174 |
| Q1 2024 | 7 973 128 | 110 421 | 613 237 | 170 |
| Q4 2023 | 9 724 711 | 25 643 | 439 022 | 172 |
| Q3 2023 | 10 014 317 | 41 525 | 523 850 | 163 |
| Q2 2023 | 12 054 189 | — | 445 170 | 162 |
| Q1 2023 | 10 018 640 | 11 362 | 474 585 | 160 |
| Q4 2022 | 12 474 771 | — | 372 968 | 149 |
| Q3 2022 | 8 502 429 | 187 181 | 401 406 | 145 |
| Q2 2022 | 9 118 891 | — | 307 674 | 145 |
| Q1 2022 | 6 835 022 | — | 293 211 | 138 |
Labour taxes per employee per month
1 022 €
Turnover per employee in the quarter
72 521 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2024 | 25 505 043 | -5 602 157 | 5 832 731 | 24 415 825 | 9 544 396 | 171 |
| 2023 | 33 308 986 | -3 121 675 | 4 993 261 | 22 948 009 | 15 146 553 | 159 |
| 2022 | 30 027 946 | -3 014 722 | 3 867 733 | 28 202 936 | 18 268 228 | 138 |
| 2021 | 29 539 530 | 420 744 | 3 091 586 | 25 543 709 | 21 282 950 | 141 |
| 2020 | 35 022 557 | 4 111 794 | 2 959 179 | 23 722 290 | 21 536 436 | 140 |
| 2019 | 25 888 462 | 1 920 814 | 2 622 990 | 20 005 567 | 17 424 642 | 132 |
| 2018 | — | — | — | — | — | 120 |
| 2017 | — | — | — | — | — | 112 |
| 2016 | — | — | — | — | — | 89 |
| 2015 | — | — | — | — | — | 88 |
| 2014 | — | — | — | — | — | 82 |
| 2013 | — | — | — | — | — | 72 |
| 2012 | — | — | — | — | — | 65 |
| 2011 | — | — | — | — | — | 65 |
| 2010 | — | — | — | — | — | 57 |
| 2009 | — | — | — | — | — | 46 |
| 2008 | — | — | — | — | — | 38 |
| 2007 | — | — | — | — | — | 36 |
| 2006 | — | — | — | — | — | 31 |
| 2005 | — | — | — | — | — | 28 |
| 2004 | — | — | — | — | — | 23 |
| 2003 | — | — | — | — | — | 10 |
| 2002 | — | — | — | — | — | 5 |
| 2001 | — | — | — | — | — | 6 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2024
Net profit margin
-21.9 %
Net profit / revenue
Return on equity (ROE)
-58.7 %
Net profit / equity
Return on assets (ROA)
-22.9 %
Net profit / assets
Equity ratio
39.1 %
Equity / assets
Debt ratio
60.9 %
Liabilities / assets
Current ratio
1.29
Current assets / current liabilities
Revenue per employee
149 268 €
Revenue / average full-time employees
Labour cost per employee per month
2 842 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 26 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 31 Mar 2025 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 9 Apr 2024 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 4 Dec 2023 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 29 Jun 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 18 Jun 2020 | Company’s own · audited | e-Äriregister |
Commercial pledges
| No. | Amount | Pledgee | Period |
|---|---|---|---|
| 4 | 620 000 € | Swedbank AS | 2 Apr 2015 – in force |
| 3 | 325 000 € | Swedbank AS | 27 Oct 2011 – in force |
| 2 | 338 230 € | Swedbank Liising Aktsiaselts | 28 Feb 2011 – in force |
| 1 | 2 600 000 EEK | Swedbank Liising Aktsiaselts | 9 Mar 2007 – in force |
Board
- Nasdaq CSD SEKeeper of the share ledger · since 28 Sep 2017
- Bernardus David Jacobus VerburgBoard member · since 15 Oct 2026
- Marco UuetaluProcurator · since 9 Jun 2026
Right of representation
Any member of the management board may represent the public limited company in all transactions.
Any procurator may represent the public limited company in all legal acts related to its business. A procurator may transfer or encumber immovable property only if that right is entered on the registry card.
Owners
No owner information.
Beneficial owners
- Anthonie Sebastiaan TesinkIndirect ownership · NLD · since 27 Jan 2026
Founders and other persons
- Eve FilonenkoAudit firm · 4 May 2017
- Alexander Bart de HaasChairman of the supervisory board · 7 May 2025
- Paul Gustave FrohnSupervisory board member · 7 May 2025
- Timo RoversSupervisory board member · 6 Oct 2026
- Omanikukonto: Interchemie B.VShareholder · 64 000 € · 22 Jul 2025
Related companies
Activities (EMTAK)
- 21201Manufacture of pharmaceutical preparations Main
- 10911Manufacture of prepared feeds for farm animals
- 46191Activities of agents involved in non-specialised wholesale
- 70201Business and other management consultancy activities
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10000532 / 27 15 Oct 2026 |
Amendment entry | In force 15 Oct 2026 |
||
| Ä 10000532 / M16 2 Oct 2026 |
Fine for not filing the report | 27 Oct 2026 | Signed 2 Oct 2026 |
|
| Ä 10000532 / M15 6 Jul 2026 |
Warning of a fine: annual report not filed | 21 Aug 2026 | In force 22 Jul 2026 |
|
| Ä 10000532 / 26 9 Jun 2026 |
Amendment entry | In force 9 Jun 2026 |
||
| Ä 10000532 / M14 30 Jan 2026 |
Procedural ruling | 9 Feb 2026 | Deficiencies eliminated 30 Jan 2026 |
|
| Ä 10000532 / 25 30 Jan 2026 |
Amendment entry | In force 30 Jan 2026 |
||
| Ä 10000532 / 24 4 Nov 2025 |
Amendment entry | In force 4 Nov 2025 |
||
| Ä 10000532 / M13 27 Oct 2025 |
Ruling to eliminate deficiencies | 12 Nov 2025 | Deficiencies eliminated 4 Nov 2025 |
|
| Ä 10000532 / 23 14 May 2025 |
Amendment entry | In force 14 May 2025 |
||
| Ä 10000532 / M12 14 Aug 2024 |
Fine for not filing the report | 29 Aug 2024 | In force 30 Aug 2024 |
|
| Ä 10000532 / M11 7 Jul 2024 |
Warning of a fine: annual report not filed | 6 Aug 2024 | In force 7 Jul 2024 |
|
| Ä 10000532 / M10 4 Mar 2024 |
Fine for not filing the report | 19 Mar 2024 | Deficiencies eliminated 10 Apr 2024 |
|
| Ä 10000532 / M9 28 Nov 2023 |
Warning of a fine: annual report not filed | 28 Dec 2023 | Deficiencies eliminated 10 Apr 2024 |
|
| Ä 10000532 / M8 27 Sep 2023 |
Warning of a fine | 27 Oct 2023 | Deficiencies eliminated 26 Oct 2023 |
|
| Ä 10000532 / M7 17 Jul 2023 |
Procedural ruling | 15 Sep 2023 | In force 17 Jul 2023 |
|
| Ä 10000532 / 22 8 Mar 2022 |
Amendment entry | In force 8 Mar 2022 |
||
| Ä 10000532 / 21 17 Dec 2021 |
Amendment under Commercial Code § 525 (2) | In force 17 Dec 2021 |
||
| Ä 10000532 / 20 12 Oct 2021 |
Amendment entry | In force 12 Oct 2021 |
||
| Ä 10000532 / 19 7 Sep 2021 |
Amendment entry | In force 7 Sep 2021 |
||
| Ä 10000532 / 18 6 Jan 2020 |
Amendment entry | In force 6 Jan 2020 |
||
| Ä 10000532 / 17 22 Nov 2019 |
Amendment entry | In force 22 Nov 2019 |
||
| Ä 10000532 / M6 6 Dec 2018 |
Ruling to correct data outside an entry | 5 Jan 2019 | Deficiencies eliminated 13 Dec 2018 |
|
| Ä 10000532 / 16 16 Jan 2018 |
Amendment entry | In force 16 Jan 2018 |
||
| Ä 10000532 / 15 7 Nov 2017 |
Amendment entry | In force 7 Nov 2017 |
||
| Ä 10000532 / 14 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 10000532 / 13 17 Nov 2016 |
Amendment under Commercial Code § 525 (2) | In force 17 Nov 2016 |
||
| Ä 10000532 / 12 20 May 2015 |
Second (constitutive) merger entry | In force 20 May 2015 |
||
| Ä 10000532 / M5 29 Apr 2015 |
Ruling to eliminate deficiencies | 29 May 2015 | Deficiencies eliminated 20 May 2015 |
|
| K 10000532 / 11 2 Apr 2015 |
Commercial pledge entered | In force 2 Apr 2015 |
||
| K 10107065 / 4 27 Oct 2011 |
Commercial pledge entered | In force 27 Oct 2011 |
||
| Ä 10000532 / 10 11 Mar 2011 |
Amendment entry | In force 11 Mar 2011 |
||
| Ä 10000532 / M4 7 Mar 2011 |
Ruling to eliminate deficiencies | 8 Apr 2011 | In force 7 Mar 2011 |
|
| K 10107065 / 3 28 Feb 2011 |
Commercial pledge entered | In force 28 Feb 2011 |
||
| K 10107065 / 2 28 Feb 2011 |
Commercial pledge amended | In force 28 Feb 2011 |
||
| Ä 532 / 9 5 Jan 2009 |
Deletion of activities from the registry card | In force 9 Jan 2009 |
||
| K 107065 8 Mar 2007 |
Commercial pledge entered | In force 9 Mar 2007 |
||
| Ä 532 / 8 22 Nov 2004 |
Amendment entry | In force | ||
| Ä 532 / M3 18 Aug 2004 |
Ruling to eliminate deficiencies (to be served) | 15 Oct 2004 | In force | |
| Ä 532 / 7 5 Aug 2003 |
Entry decision on the register’s own initiative | In force | ||
| Ä 532 / 6 15 Jul 2003 |
Amendment entry | In force |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data